Psychedelics Target Neuroimmune Interactions to Limit Fear
Research reveals how psychedelics modulate immune-to-brain communication to reduce fear, offering new therapeutic avenues for stress-related psychiatric disorders.
Posted inMedical News Neurology news Specialties
Why Does Dementia Diagnosis Take So Long? Insights from a Major Meta-Analysis
A new meta-analysis finds that the average time from dementia symptom onset to diagnosis is 3.5 years, with even longer delays in younger patients and those with frontotemporal dementia.
Empowering Parents: Acceptance and Commitment Therapy for Children With Asthma and ADHD
A randomized clinical trial demonstrates that an Acceptance and Commitment Therapy-based parenting program reduces health care use, improves asthma control, and alleviates ADHD symptoms in children with both conditions.
Regulation of Cues vs Cognitive Behavioral Therapy: Advancing Binge Eating Disorder Treatment for Veterans
ROC plus behavioral weight loss outperformed CBT in reducing binge eating among veterans, with transient advantages in weight loss. Long-term weight outcomes require further research.
Posted inMedical News Neurology news Specialties
Insufficient Sleep and Late Bedtimes: A Risk Factor for Early Puberty?
Research links insufficient sleep and late bedtimes to higher risks of central precocious puberty in girls, with notable sleep issues appearing years before puberty onset.
Can Preventing Herpes Reduce Dementia Risk? New Science Links Cold Sores, Shingles, and Alzheimer’s Disease
Emerging research reveals a compelling connection between common herpes viruses and dementia risk, with vaccination and antiviral treatments showing promise for prevention.
Posted inMedical News Neurology news Specialties
Can Preventing Herpes Reduce Dementia Risk? New Science Links Cold Sores, Shingles, and Alzheimer’s Disease
Emerging research reveals a compelling connection between common herpes viruses and dementia risk, with vaccination and antiviral treatments showing promise for prevention.
Posted inClinical Updates Neurology news Specialties
Trehalose in ALS: No Efficacy Shown in the HEALEY ALS Platform Trial
Trehalose was safe but did not slow ALS progression compared to placebo in a large, adaptive phase 2/3 trial.
Posted inNeurology news Specialties
Understanding and Managing Alzheimer’s Disease: A Comprehensive Guide
An in-depth overview of Alzheimer's disease, covering its causes, symptoms, diagnosis, treatment options, and caregiving strategies.
Safety and Effectiveness of the Walk ‘n Watch Exercise Protocol in Inpatient Stroke Rehabilitation: Insights from a Canadian Phase 3 Stepped-Wedge Trial
A Canadian multisite trial demonstrated that the Walk 'n Watch structured exercise protocol significantly improves walking endurance in subacute stroke patients during inpatient rehabilitation without increasing serious adverse events.
Posted inClinical Updates Neurology news Specialties
Neuropsychiatric Symptoms and Their Impact on Daily Functioning in Cognitively Unimpaired Older Adults
Neuropsychiatric symptoms such as decreased motivation and emotional dysregulation significantly impair daily functioning in older adults without cognitive impairment, highlighting the need for early identification and intervention.
Posted inClinical Updates Neurology news Specialties
Elevated Risk of Alzheimer’s Disease and Related Dementias in Transfeminine Adults: Insights from a Large Cohort Study
Recent data reveal that transfeminine adults experience significantly higher prevalence of Alzheimer's disease and related dementias compared to matched cisgender peers, independent of gender-affirming hormone therapy, highlighting urgent needs for targeted research and care strategies.
Lipoprotein(a) as an Independent Predictor of Peripheral Artery Disease and Carotid Stenosis: Insights from a Large UK Biobank Study
A landmark UK Biobank study demonstrates that elevated lipoprotein(a) independently predicts both the onset and progression of peripheral artery disease and carotid stenosis, beyond traditional cardiovascular risk factors.
Posted inNeurology Specialties
Tenecteplase in Modern Stroke Care: Comparative Insights from Recent Chinese Clinical Trials
Three major Chinese trials examine intravenous and intra-arterial tenecteplase as adjuncts to thrombectomy in acute large-vessel occlusion stroke, revealing functional benefit with intravenous use before thrombectomy but not after reperfusion.
Posted inNeurology news Specialties
Sex-Specific Brain Volume Loss After Traumatic Brain Injury: Greater Impact in Older Women
A study from the Framingham Heart Study cohort reveals that traumatic brain injury (TBI) is linked to significant brain volume loss in older women but not men, highlighting sex-specific vulnerability to neurodegeneration post-TBI.
Posted inClinical Updates Neurology news Specialties
Intra-arterial Tenecteplase After Thrombectomy for Acute Stroke: Interpreting the ANGEL-TNK Randomized Clinical Trial
The ANGEL-TNK trial found that intra-arterial tenecteplase after successful endovascular thrombectomy improved excellent neurological outcomes at 90 days without increasing bleeding or mortality, but secondary outcomes showed no significant benefit.
Posted inMedical News Neurology news Specialties
Legacy of Leaded Gasoline: New Evidence Links Childhood and Adult Exposure to Cognitive Impairment in Older Adults
Recent studies confirm that both childhood and adult lead exposure, especially from gasoline and industrial sources, are associated with increased risk for cognitive decline and dementia in later life.
Walking and Dietary Interventions Offer Cognitive Protection in APOE ε4 Carriers: New Evidence from Longitudinal and Multinational Trials
Regular walking and lifestyle interventions slow cognitive decline, especially in APOE ε4 carriers at heightened Alzheimer’s risk, with effects pronounced in women. Evidence underscores the value of simple activity and healthy diet for at-risk older adults.
Posted inClinical Updates Medical News Neurology
Structured Lifestyle Intervention Shows Superior Cognitive Benefits in At-Risk Older Adults: Insights from the US POINTER Trial
A large US trial shows that intensive, structured lifestyle programs yield greater cognitive improvement in at-risk older adults compared to self-guided approaches, though both are beneficial.
Posted inClinical Updates Medical News Neurology Specialties
Lecanemab in Community Practice: Real-World Safety and Efficacy for Early Alzheimer’s Disease
Community-based data suggest lecanemab is safe and effective for early-stage Alzheimer’s, with manageable ARIA rates and infusion reactions, particularly in ApoE4 noncarriers.